This educational symposium was part of the eSPACE CRM meeting held on 22-24 January 2021.
The session focuses on novel therapies for Hyperkalaemia and Anaemia.

Learning objectives
- Highlight the global burden of CKD and associated complications
- Discuss the challenges in the current management paradigm for CKD and associated complications, such as RAASi optimisation and iron management
- Review clinical and mechanistic evidence for the use of novel therapeutic interventions in treating hyperkalaemia and anaemia of CKD, in the context of traditional therapies
Symposium Agenda
- 10 mins - Welcome and Introductions - Stephen Fishbone
- 25 mins - Novel therapies for CKD complications: From evidence to practice - Adeera Levin (Canada) & Kieran McCafferty (UK)
- 20 mins - Panel discussion an Q&A - All faculty, moderated by Stephen Fishbone
- 5 mins - Future directions and Chair’s summary - All faculty
More from this programme
Part 1
Welcome & Introductions
| 1 session | |
| Welcome & Introductions | Watch now |
Part 2
Novel therapies for CKD complications: From evidence to practice
Part 3
Panel discussion an Q&A
| 1 session | |
| Panel discussion and Q&A | Watch now |
Part 4
Future directions and Chair’s summary
Faculty Biographies
Dr Adeera Levin
Dr. Adeera Levin is a Professor of Medicine, Head Division of Nephrology at the University of British Columbia, and Consultant nephrologist at Providence Health Care/ St Paul’s Hospital, in Vancouver Canada. She is also the Executive Director of the BC Renal Agency, which oversees the care, planning and budgets for Kidney services in the province of British Columbia. In this capacity, Dr. Levin has leveraged her epidemiological training, clinical knowledge, and health outcomes research to develop an evidence-based transparent system which enhances the care of patients across the continuum of care (from identification of chronic kidney disease [CKD] through to dialysis, transplant, and death).
Kieran McCafferty
Consultant Nephrologist
Dr Kieran McCafferty is a Consultant Nephrologist at Barts Health NHS Trust and a Senior Lecturer at Queen Mary University of London. His clinical work is focused on the care of patients with complex kidney disease, with particular expertise in diabetic kidney disease and haemodialysis. Alongside his clinical responsibilities, Dr McCafferty has developed a strong academic and leadership profile within nephrology and clinical research, with a clear emphasis on improving patient-centred outcomes through high-quality clinical trials.
Academic History
Dr McCafferty holds an academic appointment as Senior Lecturer at Queen Mary University of London, reflecting his combined clinical and research roles. His academic interests bridge basic science and clinical medicine, with a particular focus on uraemic cardiovascular disease and mechanisms of cardiovascular protection in patients with chronic kidney disease.
While his foundational research interests lie…